Drug Profile
Research programme: AMPA antagonists - Egis Pharmaceuticals
Alternative Names: EGIS-10608; EGIS-10609; EGIS-10733; EGIS-11229Latest Information Update: 14 Sep 2010
Price :
$50
*
At a glance
- Originator Egis Pharmaceuticals
- Class Benzodiazepines
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Epilepsy; Neurological disorders; Stroke
Most Recent Events
- 17 Oct 2007 Pharmacodynamics data from preclinical trials in Neurological disorders presented at the 20th Annual Congress of the European College of Neuropsychopharmacology (ECNP-2007)
- 21 Sep 2005 Preclinical trials in Stroke in Hungary (unspecified route)
- 21 Sep 2005 Data presented at the 230th American Chemical Society National Meeting (230th-ACS-2005) have been added to the Neurological disorders pharmacodynamics section